QNCX
Quince Therapeutics, Inc.
29.20$
-4.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.17 | 0.00 | 0.00 | 0.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | 1.41 | 0.20 | 0.40 | 0.07 | 0.15 | 0.15 | 0.13 | – | 0.14 | 9.62 | – | |
| – | – | -1.41 | -0.20 | -0.40 | -0.07 | -0.15 | -0.15 | -0.13 | – | -0.14 | -9.62 | – | |
| 7.93 | 0.08 | 17.21 | 19.25 | 22.78 | 26.93 | 37.07 | 28.07 | 29.96 | 45.23 | 27.33 | 0.89 | 5.38 | |
| 25.85 | 0.11 | 23.12 | 21.79 | 16.82 | 19.80 | 21.80 | 14.32 | 12.16 | 13.05 | 17.03 | 2.71 | 4.53 | |
| 33.79 | 0.19 | 52.16 | 130.83 | 27.17 | 46.66 | 67.63 | 42.24 | 49.79 | 58.27 | 44.22 | 13.01 | 19.65 | |
| -33.79 | -0.19 | -52.16 | -130.83 | -27.17 | -46.73 | -67.63 | -42.39 | -49.79 | -58.27 | -44.36 | -13.01 | -19.66 | |
| – | – | 2.11 | – | – | 13.54 | – | – | – | – | 2.36 | – | – | |
| -29.67 | -0.21 | -51.70 | -128.52 | -25.39 | -57.56 | -68.20 | -68.47 | -50.00 | -130.33 | 122.06 | -12.30 | -15.43 | |
| -5.10 | – | 0.14 | 0.17 | 0.06 | 0.03 | 0.21 | 0.29 | -0.17 | – | -21.31 | 0.01 | – | |
| -29.67 | -0.21 | -51.84 | -128.68 | -25.45 | -57.59 | -68.41 | -68.75 | -49.83 | -141.62 | 143.37 | -12.31 | -15.08 | |
| -29.67 | – | -40.14 | -40.83 | -39.20 | -57.49 | -58.72 | -68.32 | -41.99 | – | 122.20 | -12.30 | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.